Autolus Therapeutics (AUTL) EBITDA Margin (2018 - 2026)
Autolus Therapeutics (AUTL) reported EBITDA Margin of -90.04% for Q2 2026, up 191.15 percentage points from -281.19% a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) EBITDA Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Autolus Therapeutics' EBITDA Margin came in at -213.08%, up 660.41 percentage points year-over-year; for FY2025, it was -345.85%, up 1963.16 percentage points from FY2024.
- EBITDA Margin has a five-year change of +9128.61 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -2309.01% in FY2024 (+7887.45 pp), -10196.47% in FY2023 (-8058.32 pp), -2138.14% in FY2022 (+3552.50 pp) and -5690.64% in FY2021 (+3783.82 pp).
- The Q2 2026 figure ranks as the highest quarterly EBITDA Margin in data going back to Q3 2018.
- The high point for year-over-year EBITDA Margin in five years was Q4 2025 (a gain of 254019.38 percentage points); the low point was Q3 2021 (a drop of 11375.92 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Autolus Therapeutics | 660.38 Mn | -663.71 Mn | 25.22 Mn | -90.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -90.04% |
| Dec 31, 2025 | -287.52% |
| Sep 30, 2025 | -325.76% |
| Jun 30, 2025 | -281.19% |
| Mar 31, 2025 | -700.82% |
| Dec 31, 2024 | -254,306.90% |
| Mar 31, 2024 | -366.18% |
| Sep 30, 2023 | -10,228.08% |
| Mar 31, 2023 | -2,883.05% |
| Dec 31, 2022 | -261.46% |
| Sep 30, 2022 | -1,501.06% |
| Mar 31, 2022 | -20,553.61% |
| Dec 31, 2021 | -11,664.44% |
| Sep 30, 2021 | -16,062.29% |
| Jun 30, 2021 | -2,156.78% |
| Mar 31, 2021 | -14,204.46% |
| Dec 31, 2020 | -22,386.27% |
| Sep 30, 2020 | -4,686.36% |
| Jun 30, 2020 | -13,063.82% |
| Mar 31, 2020 | -11,036.09% |
API Access
Autolus Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();